Skip to content
Clinical Trials – home

Angiodiabetica

Research site

Poland Ul. Przemyslowa 46a/u3, 61-541 Poznan, Poland

  • Diabetic foot infection · Peripheral arterial occlusive disease
  • Adult patients

About Specializations

Angiodiabetica in Poznan, Poland specialises in clinical trials of conditions such as Diabetic foot infection, Peripheral arterial occlusive disease, and other specialisations. This site conducts important research.

Main research areas of the site

Infectious Diseases

The medical center is at the forefront of research in infectious diseases, with a particular focus on diabetic foot infections. This area of study is crucial due to the increasing prevalence of diabetes and its complications, which pose significant health challenges worldwide.

  • Diabetic Foot Infections
  • Antibiotic Resistance
  • Advanced Therapeutics

Through rigorous clinical trials, the center is evaluating the efficacy and safety of novel treatments such as contezolid acefosamil and contezolid, offering potential alternatives to traditional antibiotics like linezolid. This research not only aims to improve patient outcomes but also to address the growing concern of antibiotic resistance.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Przemyslowa 46a/u361-541 PoznanPoland
Recruiting now
no trials
Conditions studied
2

More sites in PoznanPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Efficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:REGN7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:F1245/05
  • Sponsor:Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.